Discovery Research CROs in United Kingdom
8 published
8 published CROs match Discovery Research in United Kingdom.
Locations in this set include United Kingdom, China, United States, Australia, Canada, and Denmark.
Capabilities that show up most often in this set: Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Peptide, and Oligonucleotide.
Matching companies
Aurigene Pharmaceutical Services LimitedIntegrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.
Avigen LtdAvigen offers avidity-based profiling of live immune–target cell interactions for immunotherapy discovery and preclinical validation. Its platform supports TCR-T, CAR-T, and NK programmes across solid tumour indications.
BioAscent DiscoveryBioAscent is an integrated drug discovery CRO offering medicinal and synthetic chemistry, computational chemistry, biochemical and biophysical assay development, high-throughput screening, DMPK, flow cytometry, and compound management services to biotech and pharma clients globally.
ChemPartnerGlobal preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
HitGen Inc.HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
Nexus BioQuestNexus BioQuest is an immunology-focused CRO providing preclinical drug discovery and bespoke assay design services using human primary cells and patient material to support immune-therapeutic development across oncology, autoimmunity, and inflammation.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Sygnature DiscoveryIntegrated drug discovery CRO covering target identification through lead optimization, with computational design, structural biology, medicinal chemistry and DMPK support. Serves biotech and pharma clients across the US, Canada, UK and Europe.
Markdown mirror: /services/discovery-research/united-kingdom.md